Terms: = Kidney tumors AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
17451 results:
1. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
Xue Z; Tang S; Ou J; Fang Y; Qiu M; Hong K; Tian X; Zhang H; Liu C; Ma L; Zhang S
World J Urol; 2024 May; 42(1):364. PubMed ID: 38819448
[TBL] [Abstract] [Full Text] [Related]
2. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Mehra R; Nallandhighal S; Cotta B; Knuth Z; Su F; Kasputis A; Zhang Y; Wang R; Cao X; Udager AM; Dhanasekaran SM; Cieslik MP; Morgan TM; Salami SS
JCO Precis Oncol; 2024 May; 8():e2300565. PubMed ID: 38810179
[TBL] [Abstract] [Full Text] [Related]
3. Urinary calprotectin as a diagnostic tool for detecting significant bacteriuria.
Waldecker-Gall S; Waldecker CB; Babel N; Baraliakos X; Seibert F; Westhoff TH
Sci Rep; 2024 May; 14(1):12230. PubMed ID: 38806578
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab.
Yoshimura A; Nagahara A; Ishizuya Y; Yamamoto Y; Hatano K; Kawashima A; Nakai Y; Nakayama M; Nishimura K; Nonomura N; Kato T
Clin Exp Med; 2024 May; 24(1):111. PubMed ID: 38780659
[TBL] [Abstract] [Full Text] [Related]
6. Trends and predictors of changes in renal function after radical nephrectomy for renal tumours.
Yan Y; Liu Y; Li B; Xu S; Du H; Wang X; Li Y
BMC Nephrol; 2024 May; 25(1):174. PubMed ID: 38773467
[TBL] [Abstract] [Full Text] [Related]
7. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: which dose is more suitable?
Ilhan Y; Onder AH; Ozbay MF; Karakaya G; Sezgin Goksu S; Ozturk B; Coskun HS
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3403-3413. PubMed ID: 38766796
[TBL] [Abstract] [Full Text] [Related]
8. Modeling Physical Forces Experienced by Cancer and Stromal Cells Within Different Organ-Specific Tumor Tissue.
Connaughton M; Dabagh M
IEEE J Transl Eng Health Med; 2024; 12():413-434. PubMed ID: 38765886
[TBL] [Abstract] [Full Text] [Related]
9. Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients.
Fu Y; Zhong J; Tan Y; Zheng T; Liu M; Wang G
Sci Rep; 2024 May; 14(1):11409. PubMed ID: 38762673
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
11. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract] [Full Text] [Related]
12. Minimally invasive transperitoneal partial versus radical nephrectomy in obese patients: perioperative and long-term functional outcomes from a large perspective contemporary series (RECORd2 project).
Lambertini L; Mari A; Sandulli A; Amparore D; Antonelli A; Barale M; Bove P; Brunocilla E; Capitanio U; DA Pozzo LF; DI Maida F; Grosso AA; Fiori C; Gontero P; Li Marzi V; Campi R; Longo N; Marchioni M; Montanari E; Montorsi F; Porpiglia F; Porreca A; Schiavina R; Simeone C; Siracusano S; Terrone C; Ficarra V; Minervini A
Minerva Urol Nephrol; 2024 Apr; 76(2):185-194. PubMed ID: 38742553
[TBL] [Abstract] [Full Text] [Related]
13. Single-layer versus double-layer renorrhaphy technique during robot-assisted partial nephrectomy: impact on perioperative outcomes, complications, and functional outcomes.
Bertolo R; Ditonno F; Veccia A; DE Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A
Minerva Urol Nephrol; 2024 Apr; 76(2):176-184. PubMed ID: 38742552
[TBL] [Abstract] [Full Text] [Related]
14. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
[TBL] [Abstract] [Full Text] [Related]
15. Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma.
Sammarco E; Rossetti M; Salfi A; Bonato A; Viacava P; Masi G; Galli L; Faviana P
Med Oncol; 2024 May; 41(6):150. PubMed ID: 38740647
[TBL] [Abstract] [Full Text] [Related]
16. Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.
Liu K; Li Q; Lu X; Fan X; Yang Y; Xie W; Kang J; Sun S; Zhao J
Pharm Biol; 2024 Dec; 62(1):404-422. PubMed ID: 38739082
[TBL] [Abstract] [Full Text] [Related]
17. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
[TBL] [Abstract] [Full Text] [Related]
18. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
[TBL] [Abstract] [Full Text] [Related]
19. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study.
Zhao QX; Wu C; Tan S; Yang Y; Cui XW; Dietrich CF; Yang B; Xu CL; Gao YY; Xie MX; Wu CJ; Liu LP; Wang XH; Ling-Hu RZ; Wang N; Wang F; Wang XL; Liu GY; Yu XL; Yu J; Cheng ZG; Liang P
World J Urol; 2024 May; 42(1):302. PubMed ID: 38720010
[TBL] [Abstract] [Full Text] [Related]
20. Development and validation of prognostic nomograms for adult with papillary renal cell carcinoma: A retrospective study.
Guo Q; Li S; Zhu J; Wang Z; Li Z; Wang J; Wen R; Li H
Clinics (Sao Paulo); 2024; 79():100374. PubMed ID: 38718696
[TBL] [Abstract] [Full Text] [Related]
[Next]
